Go Pro
NASDAQ:COSM

Cosmos Health Q3 2025 Earnings Report

Cosmos Health logo
$0.32 +0.02 (+7.26%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$0.32 +0.01 (+1.64%)
As of 09/18/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cosmos Health EPS Results

Actual EPS
-$0.17
Consensus EPS
-$0.01
Beat/Miss
Missed by -$0.16
One Year Ago EPS
N/A

Cosmos Health Revenue Results

Actual Revenue
$17.11 million
Expected Revenue
$16.40 million
Beat/Miss
Beat by +$710.43 thousand
YoY Revenue Growth
N/A

Cosmos Health Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Cosmos Health's next earnings date is estimated for Friday, November 13, 2026, based on past reporting schedules.

Conference Call Resources

Cosmos Health Earnings Headlines

Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon adviser Jim Rickards publicly predicted a Trump victory before election night. Now Rickards is issuing a new forecast he calls a potential mid-term meltdown, one he believes could send shockwaves through financial markets.tc pixel
See More Cosmos Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email.

About Cosmos Health

Cosmos Health (NASDAQ:COSM) is a global healthcare group focused on pharmaceuticals, nutraceuticals and healthcare-related services. The company develops, manufactures and distributes branded and generic pharmaceutical products, over-the-counter medicines, medical devices and nutritional supplements through its subsidiaries and commercial partners.

Cosmos Health’s portfolio includes Sky Premium Life, a line of premium nutritional supplements, as well as pharmaceutical manufacturing operations associated with Cana Laboratories in Greece. Its businesses serve customers and distribution channels in markets including Europe, the United Kingdom, Greece and the United States, although product availability varies by geography and regulatory requirements.

Founded in 2009, Cosmos Health has expanded through the development of its own healthcare brands and acquisitions in the pharmaceutical and healthcare sectors. The company is led by Greg Siokos, who serves as chief executive officer and has been associated with the company since its founding.

View Cosmos Health Profile